Kanter Stacy J.
SEC insider (Form 3/4/5 filer). CIK 0001775404. Director at OPPENHEIMER HOLDINGS INC (OPY) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 26, 2026. Located in NEW YORK, NY.
Companies Kanter Stacy J. has filed insider reports for
- OPPENHEIMER HOLDINGS INC (OPY): Director
- Applied Therapeutics, Inc. (APLT): Director
Kanter Stacy J.
CIK: 0001775404
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 26, 2026OPY
OPPENHEIMER HOLDINGS INC
OtherDirect1.4K shares- - Feb 3, 2026APLT
Applied Therapeutics, Inc.
DispositionDirect22.5K shares- - Feb 3, 2026APLT
Applied Therapeutics, Inc.
Tender OfferDirect42.5K shares- - Dec 16, 2025APLT
Applied Therapeutics, Inc.
SaleDirect43K shares at avg. $0.11$5K - Jun 9, 2025APLT
Applied Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
200K shares- - Jan 30, 2025OPY
OPPENHEIMER HOLDINGS INC
OtherDirect1.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 26, 2026 |  OPY OPPENHEIMER HOLDINGS INC | Other | 1,400 | - | $0 | Direct |
| Feb 3, 2026 |  APLT Applied Therapeutics, Inc. | Disposition | 22,500 | - | $0 | Direct |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | Tender Offer | 42,500 | - | $0 | Direct |
| Dec 16, 2025 | APLT Applied Therapeutics, Inc. | Sale | 43,000 | $0.11 | $4,816 | Direct |
| Jun 9, 2025 | APLT Applied Therapeutics, Inc. | Award Stock Option (Right to Buy) | 200,000 | - | - | Direct |
| Jan 30, 2025 | OPY OPPENHEIMER HOLDINGS INC | Other | 1,500 | - | $0 | Direct |
1-6 of 6 transactions